6,041
Views
20
CrossRef citations to date
0
Altmetric
Position Papers

EMS Management of Acute Stroke—Out-of-Hospital Treatment andStroke System Development (Resource Document to NAEMSP Position Statement)

, MD, MPH, , MD & , MD, MS
Pages 318-325 | Received 19 Mar 2007, Published online: 02 Jul 2009

Abstract

The American Heart Association estimates an annual incidence of stroke in the United States at 700,000, leading to over 150,000 deaths. Of all strokes, approximately 88% are ischemic and12% are hemorrhagic. Almost half of all stroke deaths occur in the out-of-hospital environment.Citation Within a given region, the emergency medical services (EMS) system has an important role in the management of the acute stroke patient. Decisions made by EMS personnel can affect treatment andcontribute to the immediate, short-term, andlong-term outcomes of the patient. Because the patient may require emergent treatment regardless if the stroke is ischemic or hemorrhagic, EMS personnel should manage all potential stroke patients in a time-dependent nature. Proper treatment anddisposition of the stroke patient begins in the out-of-hospital environment, continues in the emergency department, andthen extends to the inpatient admission. This article reviews the literature on the out-of-hospital treatment of stroke patients andthe role of EMS in the development of stroke systems of care.

Introduction

The American Heart Association estimates an annual incidence of stroke in the United States at 700,000, leading to over 150,000 deaths. Of all strokes, approximately 88% are ischemic and12% are hemorrhagic. Almost half of all stroke deaths occur in the out-of-hospital environment.Citation1 If recent trends continue, the 30-year projections suggest a 98% absolute increase in stroke deaths from 139,000 in 2002 to 275,000 in 2032 with a corresponding increase in the U.S. population of only 27%.Citation2

Within a given region, the emergency medical services (EMS) system has an important role in the management of acute stroke patients. Decisions made by EMS personnel can affect treatment andcontribute to the immediate, short-term, andlong-term outcomes of the patient.

The first step for EMS is the early identification of patients who may be having a stroke. This begins with entry of the patient into the EMS system via “911” or equivalent emergency call centers. Once potential stroke patients have been entered into the EMS system, it then falls to the responsibility of the on-scene EMS personnel to accurately screen andassess potential stroke patients. Because the patient may require emergent treatment regardless if the stroke is ischemic or hemorrhagic, EMS personnel should manage all potential stroke patients in a time-dependent nature.

In 1995, the National Institute of Neurological Disorders andStroke (NINDS) published a study in which tissue plasminogen activator (t-PA), given within 3 hours of symptom onset, improved outcome for patients with acute ischemic stroke.Citation3 The NINDS study showed that patients given t-PA were more likely to have minimal or no disability at 3 months compared to placebo (favorable outcome by Barthel index of 50% compared to 38%, respectively; relative improvement of 31.6%). At the same time, however, patients given t-PA were at a statistically significant higher risk for intra-cerebral hemorrhage within 36 hours than the placebo group at 6.4% compared to 0.6% respectively (increased relative risk of 9.7%).

Over the past 10 years there has been much controversy over the use of t-PA for acute ischemic stroke. Much of this controversy has revolved around protocol violations andthe exact subset of patients that are appropriate to receive t-PA.Citation4, Citation5 Another element of the controversy has been related to the statistical methods used in the NINDS trial. Some authors have argued that the results are not valid due to an imbalance in the study groups.Citation6 Because of this concern, a group of independent reviewers recently published results on a reanalysis of the findings from the NINDS trial. Their findings reaffirmed support for the use of t-PA to treat patients with acute ischemic stroke within 3 hours of onset of symptoms, despite an increased incidence of symptomatic intracranial hemorrhage.Citation7, Citation8

Regardless of the findings from the independent commission, there continues to be only a small fraction of acute stroke patients who are eligible for thrombolytics due to the restrictive inclusion criteria.Citation9 However, beyond the use of intravenous t-PA for the treatment of acute ischemic stroke, there are other treatment modalities that may be beneficial for stroke patients. Many of these additional treatment modalities may be initiated in the out-of-hospital environment andcontinued in the emergency department andfollowing admission. The ideal agent for field use would be a neuroprotective agent that could be administered during transport.Citation10, Citation11 However, to date, no neuroprotective agent has been shown to be effective in reducing the morbidity or mortality associated with acute ischemic stroke.

In addition to stroke specific therapies, there are several other treatment measures that should be considered by all EMS personnel when caring for the patient with a potential stroke. These measures include position of patient during transport, use of oxygen therapy andairway management, placement of intravenous lines andadministration of intravenous fluids, electrocardiographic monitoring, blood glucose monitoring andcorrection of hypoglycemia, administration of aspirin, andmonitoring of blood pressure derangements. In the emergency department, acute stroke patients should be assessed for potential candidacy for intravenous or intra-arterial t-PA, or neurosurgical consultation for hemorrhagic stroke. Once the patient has been admitted, acute stroke patients should be managed in consultation with a neurologist andassessed for short-term (e.g., fever, blood glucose derangements, blood pressure derangements, aspiration pneumonia, deep venous thrombosis) andlong-term (i.e., rehabilitation, psychological health) sequela of stroke.

Recently, two independent groups, the Brain Attack Coalition (BAC) andthe American Stroke Association (ASA), a division of the American Heart Association, have developed recommendations for the treatment of stroke patients andthe development of stroke centers.Citation12, Citation13 The recommendation that all acute stroke patients receive treatment at accredited stroke centers has significant implications because many acute stroke patients are transported to acute care centers through the EMS system. The early identification of the potential stroke patient andsubsequent transport to an appropriate care facility is the responsibility of the EMS system. Therefore, EMS medical directors should develop regional protocols for the identification andtreatment of potential stroke patients andshould be involved in the development of any regional stroke systems of care.

Review of Supporting Literature

Out-of-Hospital Screening for Stroke Patients

Because the outcome of some stroke treatments is time dependent, it is important to rapidly enter a patient who is possibly experiencing a stroke into the EMS system. Entry into the EMS system begins with the “911” or equivalent emergency operator andcontinues with the EMS personnel that provide direct care to the patient.

For EMS personnel to accurately identify a patient who may be having a stroke, it is valuable to have a screening tool that is easy to perform. Two stroke screening assessments have been documented to have a high sensitivity in identifying patients who may be having a stroke in the out-of-hospital setting: the Cincinniti Prehospital Stroke Scale andthe Los Angeles Prehospital Stroke Screen.Citation14, Citation15 It is recommended that all EMS personnel use a screening tool for the assessment of patients who may be having a stroke.

Out-of-Hospital Treatment of Stroke Patients

Transport Position

The primary aim of acute stroke treatment is to restore blood flow to poorly oxygenated brain tissue. Positioning of the head at zero degrees, or supine, during assessment andtransportation may increase arterial blood flow through the effects of gravity. Traditional positioning for most acute neurological conditions has been with 30° of head elevation to decrease intracranial pressure (ICP).Citation16, Citation17, Citation18 However, in ischemic stroke patients, ICP does not peak until 48 hours postinfarction, andincreased blood flow may be more beneficial in the acute setting.Citation19, Citation20 Schwartz et al. demonstrated an improvement in cerebral perfusion pressure (CPP) from 64.7 ± 1.7 mmHg with a 30° elevation to 77± 1.8 mmHg with a flat position (p < 0.001).Citation21 ICP changes were found to be clinically insignificant. Wojner-Alexandrov et al. demonstrated a 20% improvement in middle cerebral artery (MCA) blood flow in a flat position compared to 30° of head elevation with no detrimental effects noted.Citation22

As of this date, there are no published studies that have examined head positioning of stroke patients in the out-of-hospital setting. Furthermore, proper assessment andmanagement of airway, breathing, andcirculation are of primary importance in acute stroke. Stroke patients may need stabilization of airway andtransportation with aspiration precautions. Therefore, the benefits andrisks of flat head positioning in the prehospital setting are unknown at this time, andfurther studies need to be performed. However, a flat assessment andtransport position for patients with acute stroke that have no clinical evidence of elevated ICP andcan tolerate positional changes may improve blood flow to the brain.

Oxygen

Supplemental oxygen therapy is frequently a routine intervention in the prehospital patient with acute stroke. Decreases in oxygen saturation can lead to worsening of cerebral ischemia.Citation23 Furthermore, administration of supplemental oxygen to those that are not hypoxic may improve oxygen supply to ischemic tissue andthereby minimize the ischemic penumbra.

Animal studies have suggested that there may be some benefit to administering 100% supplemental oxygen to nonhypoxic ischemic stroke victims.Citation24, Citation25 However, human studies that have compared the use of supplemental oxygen to no oxygen therapy for stroke patients have shown no additional improvement of outcomes with oxygen administration.Citation26, Citation27 The use of hyperbaric oxygen therapy has also been shown to have no benefit in the treatment of stroke.Citation28 Furthermore, there is some evidence that suggests that hyperoxia may be harmful.Citation29, Citation30 Currently, the best evidence with regards to the use of oxygen is in the maintenance of homeostasis.Citation31 Stroke units that have tried to maintain normal oxygen saturation in addition to euglycemia andnormothermia have demonstrated the best stroke outcomes.Citation31, Citation32, Citation33

Current recommendations based on available literature are to monitor oxygen saturation continuously with a pulse oximeter andtreat hypoxia with supplemental oxygen. Because there is no conclusive evidence that supplemental oxygen for those that are not hypoxic causes harm, clinicians may consider the use of oxygen in stroke for patients who are not hypoxic.Citation34 However, because the goal of treatment should be to maintain normoxia, supplemental oxygen for those who are not hypoxic should be given at low flow rates. Additional research is needed to determine if there are any benefits or harm from the use of supplemental oxygen in nonhypoxic acute stroke patients.

IV Access

Since acute stroke should be treated as a time-dependent emergency, rapid transport to a definitive care facility is of utmost importance. Delays in the prehospital setting need to be avoided. One potential time delay relates to the establishment of intravenous (IV) access. A field line may be appropriate for cases when acute resuscitation medications are needed. Otherwise, transportation should be started immediately andIV access secured en route. Although paramedics have demonstrated proficiency at prehospital line placement, attempts prior to transport can lead to increased scene time.Citation35, Citation36, Citation37

In the hospital, intravenous lines are useful for obtaining blood for laboratory tests andfor administering medications including contrast agents during imaging. The current imaging gold standard for acute stroke is computed tomography (CT) without contrast to separate hemorrhagic from ischemic stroke.Citation38, Citation39 Other imaging modalities that are being used with increased frequency include magnetic resonance imaging (MRI) with or without contrast, diffusion weighted imaging with MRI, CT angiography, andCT perfusion imaging. MRI contrast is administered manually such that the size of the line is not crucial. However, contrast CTs are performed with power injectors that often require IV lines to be large bore andno more distal than the antecubital fossa.

The current recommendations for patients not requiring acute resuscitation are to minimize scene time andto establish IV access en route. Medical directors should know the diagnostic capabilities of area hospitals andencourage EMS units to establish IV access to meet these needs. Assuming that establishing an IV does not increase the EMS transport time, placing a line that meets therapeutic anddiagnostic requirements may save critical time by eliminating the need to establish an IV as a first priority when the patient arrives at the hospital.Citation10, Citation11

IV Fluid Administration

Once vascular access has been established, there is a tendency for EMS providers to administer intravenous fluids. However, it remains unclear what type of fluid to administer andhow much to give. In theory, hemodilution will decrease viscosity, improve cerebral blood flow, andsubsequently decrease infarct size. A Cochrane review on hemodilution for acute stroke using plasma volume expanders concluded that this therapy has not been proven to improve survival or functional outcome.Citation40 The administration of hypertonic saline has also been recommended to decrease ICP in the setting of acute stroke.Citation41 However, correcting ICP in the prehospital setting where it cannot be measured or monitored is potentially dangerous. In an animal study using hypertonic saline acutely for stroke without regard to monitoring ICP, hypertonic saline was shown to worsen the infarct size of cortical infarcts.Citation42 Glucose-containing solutions must be avoided because hyperglycemia has been shown to be detrimental in the acute setting.Citation43, Citation44

IV fluids should be used cautiously in stroke patients with other underlying medical conditions such as heart failure or renal failure in which volume overload could be detrimental. Conversely, patients who are dehydrated or poorly perfusing, should receive boluses of balanced salt solutions to improve circulation andpotentially cerebral blood flow.Citation45, Citation46 No benefit from routine hemodilution has yet been demonstrated for use in the acute setting. In patients who are hemodynamically stable, the current recommendation is to saline lock the line or run a balanced salt solution at a minimal rate to keep the line open (TKO).

Electrocardiographic (ECG) Monitoring

Stroke patients are at risk for adverse cardiac outcomes as mediated through an increase in sympathetic tone andthe release of catecholamines causing a proarrhythmic state.Citation47, Citation48, Citation49, Citation50 The increase in tone can also cause heart strain andmyocardial infarction.Citation51 Potential ECG changes include QT prolongation, T-wave flattening or inversion, ST segment alteration, andsupraventricular dysrhythmias.Citation52, Citation53 Moreover, stroke itself can be caused by the release of blood clots associated with underlying atrial fibrillation or prior myocardial infarction. Given the wide range of cardiac risk factors andcomplications, continuous three-lead ECG monitoring, when available, is recommended for all cases.

Blood Glucose Monitoring

In the setting of acute stroke symptoms, capillary blood glucose (CBG) measurement should be obtained as soon as possible. Early hypoglycemic patients can present with focal neurological findings that mimic a stroke.Citation54 In addition, severe andprolonged hypoglycemia can lead to brain injury such that prompt identification andcorrection of hypoglycemia is imperative.

The identification of hyperglycemic patients is also important. Hyperglycemia is recognized as an independent risk factor for increased morbidity andmortality following stroke.Citation43, Citation44, Citation55 Hyperglycemia worsens cerebral edema, enhances hemorrhagic transformation of the stroke, andexacerbates the postischemic injury.Citation56, Citation57 The underlying mechanisms include increased anaerobic glycolysis leading to tissue acidosis as well as increased permeability of the blood brain barrier. Recent studies have identified the importance of starting early insulin therapy to achieve euglycemia.Citation58, Citation59 Ongoing prospective trials to evaluate early glucose regulation will hopefully show the ideal interventions to improve long-term outcomes.Citation60, Citation61 In the future, early management of hyperglycemia may be warranted in the prehospital setting. However, at present, no data exist to support this treatment.

In summary, it is important to check a CBG early to identify andtreat hypoglycemic patients as well as identify hyperglycemic patients so that early in-hospital intervention can be started to establish euglycemia.

Aspirin

The goal of early intervention in acute ischemic stroke is to restore blood flow to brain tissue by physically disrupting the clot andpreventing further clot formation. Platelets are believed to play an important role in the pathogenesis of acute ischemic stroke andthe antiplatelet drug aspirin has been demonstrated to have beneficial effects in the treatment of acute stroke.Citation62, Citation63 The International Stroke Trial (IST) andthe Chinese Acute Stroke Trial (CAST) evaluated the effects of early aspirin therapy (within 48 hours) on acute stroke andshowed a reduction in the immediate risk of further stroke or death in the hospital setting andin the overall risk of death or dependency.Citation64, Citation65

In theory, giving aspirin to a person with a hemorrhagic stroke could worsen the bleeding. However, a subgroup analysis of the IST andCAST studies showed a net benefit with no unusual risk of hemorrhagic stroke in the use of early aspirin therapy.Citation66 Other studies have also failed to show an increased risk in the development or worsening of hemorrhagic stroke with the use of aspirin.Citation67, Citation68, Citation69

There is no literature that has examined the benefits andrisks of aspirin therapy for suspected stroke in the prehospital environment. Because the available literature does not show an increased risk of hemorrhage, aspirin could theoretically be given to patients with suspected stroke in the prehospital environment. However, as the literature demonstrates a benefit to aspirin therapy when given in the first 48 hours after onset of symptoms andthere is a theoretical risk of hemorrhage, it is acceptable to delay aspirin therapy until after the patient has arrived at the emergency department. Further research is needed to delineate the benefits andrisks of aspirin administration for suspected stroke patients in the prehospital environment.

Blood Pressure Management

Blood pressure management in acute stroke has been a controversial topic.Citation70 In theory, a reduction in blood pressure should prevent additional strokes, reduce further vascular damage, decrease cerebral edema, andlessen the chance for hemorrhagic transformation of an ischemic area.Citation71 However, reducing blood pressure could also reduce cerebral perfusion andlead to enlargement of the area at risk for ischemic injury. Cerebral autoregulation is often disrupted in the setting of ischemia, andcerebral perfusion depends almost entirely on systemic arterial blood pressure. In studies that focused on the first 24 hours after an acute ischemic stroke, it has been noted that although initial hypertension is common, blood pressure often declines without intervention in the first 90 minutes.Citation72, Citation73 Other studies have found that the initial hypertension associated with an acute ischemic stroke was protective andthat interventions to lower it in the first 24 hours worsened outcome.Citation74, Citation75, Citation76

For ischemic stroke, a range of systolic blood pressure (SBP) from 140 to 180 mmHg appears to be optimal andreducing SBP below 140 mmHg or by more than 20 mmHg is detrimental.Citation76 In fact, evidence is emerging for the use of vasopressors to increase SBP in the management of acute ischemic stroke.Citation77, Citation78 Current recommendations for blood pressure management in ischemic stroke are to avoid anti-hypertensives in the acute setting unless SBP is > 220 mmHg or if medically necessary for treating accompanying conditions such as acute myocardial infarction, decompensated heart failure, aortic dissection, acute renal failure, or hypertensive encephalopathy.Citation79 In hemorrhagic stroke, the goal of blood pressure management is to maintain mean arterial blood pressure < 130 mmHg andCPP > 70 mmHg.Citation80

Because of the importance of not overaggressively treating hypertension in acute stroke, blood pressure management in acute stroke should be done in a controlled manner with continuous assessment andclose titration of medications used. Because it is very difficult to closely monitor blood pressures andtitrate medications in the prehospital environment, current recommendations for the management of blood pressure in the prehospital environment for potential stroke patients are to not intervene andto let the body autoregulate.

Level of Prehospital Care

The availability of advanced life support (ALS) level prehospital care varies from community to community. In communities where ALS care is not immediately available, basic life support (BLS) services can provide prompt andcoordinated care of patients with suspected acute stroke, andtransport should not be delayed when ALS care is not immediately available. Unless resuscitation is required, the BLS skills of early recognition of patients with suspected acute stroke, prompt transport, andcoordination of care with the receiving facility are of more importance than the ALS skills listed above.

Stroke Centers

As recently as 2000, Alberts et al. published recommendations from the BAC for the establishment of primary stroke centers.Citation81 These recommendations have since been adopted by the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) for the accreditation of primary stroke centers.Citation82 The recommendations from the BAC focus on two main objectives: patient care areas andsupport services.

Since the publication of the original recommendations by the BAC, this organization, composed of a multidisciplinary group representing a variety of professional organizations andmedical specialties, has subsequently published further recommendations for the development of comprehensive stroke centers.Citation12 It is the belief of the BAC that there should be two levels of stroke centers: (1) primary centers that are able to provide care for most acute stroke patients and(2) comprehensive stroke centers that act as a referral center for complex cases as well as provide a base for stroke education. In addition to these recommendations, the ASA has also published recommendations for the establishment of stroke systems.Citation13

Both the BAC andthe ASA recommendations include sections on EMS andthe management of stroke patients. These recommendations highlight the importance of early identification andnotification to receiving hospitals of potential stroke patients, appropriate treatment of these patients, andtransport and/or transfer to area stroke centers. Recommendations from the BAC stress the importance of continuing education programs on stroke for EMS personnel andthe integration of the EMS system with the greater medical community in the development of stroke systems. The recommendations from the ASA focus on the appropriate identification of stroke patients, dispatch of appropriate level of service to these patients, andtimely transport to stroke centers.Citation13

To this date, there have been no studies published that have compared outcomes in patients who are primarily transported to a stroke center to patients primarily transported to a non-stroke center. However, there have been a number of studies published that have demonstrated improved outcomes when patients are either admitted to a stroke unit or receive specialized stroke care.Citation83, Citation84, Citation85, Citation86, Citation87, Citation88 There are many possible reasons for improved outcomes when a patient is admitted to a stroke center.

In a prospective study of patients admitted to nine VA hospitals with acute ischemic stroke, Goldstein et al. demonstrated that patients cared for by neurologists have improved outcomes.Citation89 Mitchell et al. published similar findings in their study in which stroke patients treated by a neurologist had a 22% less mortality rate than similar patients treated by an internist.Citation90 A few of the possible explanations for improved outcomes when stroke patients are managed by a neurologist might be: focused diagnostics, appropriate treatment, prevention of complications, andrehabilitation.

On the basis of the available literature demonstrating improved outcomes when stroke patients receive specific treatment plans, JCAHO has published a list of 10 measures that should be considered in the certification of stroke centers.Citation91, Citation92 While many of these measures can be accomplished at a typical community hospital, the coordination of all of these measures by a neurologist at an accredited stroke center has the potential to lead to improved outcomes in the care of stroke patients.

Implications for EMS Systems

Emergency medical services systems are a vital component to the management of stroke patients. There continue to be emerging treatment modalities for stroke patients that are applicable to the out-of-hospital environment. Therefore, EMS medical directors should develop protocols that address a multitude of issues related to the care of stroke patients. These protocols may include appropriate identification andtreatment of stroke patients as well as the integration of the EMS system into regional stroke systems.

For the identification of potential stroke patients, EMS medical directors should include training in stroke screening as a part of the formal curriculum within the EMS system. EMS providers working in emergency dispatch centers as well as in the field should use a standardized method to identify andassess patients who may be having a stroke. Standardized screening is an important tool in early identification of potential stroke patients.

For the treatment of stroke patients, protocols should address position of patient during transport, use of oxygen therapy andairway management, placement of intravenous lines andadministration of intravenous fluids, electrocardiographic monitoring, blood glucose monitoring andcorrection of hypoglycemia, administration of aspirin, andmonitoring of blood pressure derangements. These protocols should be continuously reviewed to reflect current evidence-based treatment practices. EMS providers should also have regular continuing education in the evaluation andtreatment of potential stroke patients.

Regarding stroke centers, there may be times when primary transportation to a stroke center is not feasible within an EMS system. There may be some EMS systems that will not have a stroke center in the geographic region. Some EMS systems may be in areas where primary transportation will require excessively long transports taking an EMS unit out of its primary coverage area. There may also be times when primary transportation to a stroke center may be contraindicated such as if the primary hospital is not the closest hospital andthe patient is in need of emergent treatment for situations such as a compromised airway. However, in these situations when primary transportation to a stroke center is not feasible, secondary transfer of these patients to a hospital with specialized stroke services may be necessary.

Regarding the development of stroke systems of care, EMS medical directors andadministrators should be active participants, if not leaders, in the development of regional stroke systems. It is important to note that there is controversy in the concept of developing stroke systems of care. There are no data that demonstrate improved outcomes when patients are primarily transported to stroke centers. However, there are data that show improved outcomes when patients are ultimately cared for at a hospital with the capacity to deliver specialized stroke care, even if this means secondary transfer from the facility where the initial therapy, including the decision to administer or not administer thrombolytics, is made. Therefore, EMS systems andmedical directors should take a leadership role in developing local andregional strategies for the transportation of patients with acute stroke symptoms. These strategies should include the indentification of (1) centers that are capable of providing acute stroke treatment (e.g., thrombolysis) andthe criteria for identifying the patients who should be transported from the scene to these centers and(2) centers that have the capacity to deliver postacute stroke care, andEMS systems should anticipate andbe able to accommodate potential secondary transfers of patients if they are initially taken to a center that doesn't offer these services.

References

  • Heart Disease andStroke Statistics–2005 Update. American Heart Association, http://www.americanheart.org/presenter.jhtml?identifier=1200026 Available at, Accessed Novemebr 7, 2005
  • Elkins J S, Johnston S C. Thirty-year projections for deaths from ischemic stroke in the United States. Stroke 2003; 34(9)2109–12
  • Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders andStroke rt-PA Stroke Study Group. N Engl J Med 1995; 333(24)1581–87
  • Katzan I L, Furlan A J, Lloyd L E, Frank J I, Harper D L, Hinchey J A, Hammel J P, Qu A, Sila C A. Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. JAMA 2000; 283(9)1151–8
  • Bravata D M, Kim N, Concato J, Krumholz H M, Brass L M. Thrombolysis for acute stroke in routine clinical practice. Arch Intern Med 2002; 162(17)1994–2001
  • Lenzer J. Alteplase for stroke: money andoptimistic claims buttress the “brain attack” campaign. BMJ 2002; 324(7339)723–9
  • Ingall T J, O'Fallon W M, Asplund K, Goldfrank L R, Hertzberg V S, Louis T A, Christianson T J. Findings from the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial. Stroke 2004; 35(10)2418–24
  • O'Fallon W M, Asplund K, Goldfrank L R, Hertzberg V S, Ingall T, Louis T A, http://wwwnindsniggov/t-PA_review_committee Report of the t-PA Review Committee. National Institute of Neurological Disorders andStroke Available at, Accessed November 7, 2005
  • O'Connor R E, McGraw P, Edelsohn L. Thrombolytic therapy for acute ischemic stroke: why the majority of patients remain ineligible for treatment. Ann Emerg Med 1999; 33(1)9–14
  • Crocco T, Gullett T, Davis S M, Flores N, Sauerbeck L, Jauch E, Threlkeld B, Pio B, Ottaway M, Pancioli A, Chenier T. Feasibility of neuroprotective agent administration by prehospital personnel in an urban setting. Stroke 2003; 34(8)1918–22
  • Saver J L, Kidwell C, Eckstein M, Starkman S. Prehospital neuroprotective therapy for acute stroke: results of the Field Administration of Stroke Therapy-Magnesium (FAST-MAG) pilot trial. Stroke 2004; 35(5)e106–108
  • Alberts M J, Latchaw R E, Selman W R, Shephard T, Hadley M N, Brass L M, Koroshetz W, Marler J R, Booss J, Zorowitz R D, Croft J B, Magnis E, Mulligan D, Jagoda A, O'Connor R, Cawley C M, Connors J J, Rose-DeRenzy J A, Emr M, Warren M, Walker M D. Recommendations for comprehensive stroke centers: a consensus statement from the Brain Attack Coalition. Stroke 2005; 36(7)1597–616
  • Schwamm L H, Pancioli A, Acker J E, 3rd, Goldstein L B, Zorowitz R D, Shephard T J, Moyer P, Gorman M, Johnston S C, Duncan P W, Gorelick P, Frank J, Stranne S K, Smith R, Federspiel W, Horton K B, Magnis E, Adams R J. Recommendations for the establishment of stroke systems of care: recommendations from the American Stroke Association's Task Force on the Development of Stroke Systems. Circulation 2005; 111(8)1078–91
  • Kothari R U, Pancioli A, Liu T, Brott T, Broderick J. Cincinnati Prehospital Stroke Scale: reproducibility andvalidity. Ann Emerg Med 1999; 33(4)373–8
  • Kidwell C S, Starkman S, Eckstein M, Weems K, Saver J L. Identifying stroke in the field. Prospective validation of the Los Angeles prehospital stroke screen (LAPSS). Stroke 2000; 31(1)71–6
  • Kenning J A, Toutant S M, Saunders R L. Upright patient positioning in the management of intracranial hypertension. Surg Neurol 1981; 15(2)148–52
  • Rosner M J, Coley I B. Cerebral perfusion pressure, intracranial pressure, andhead elevation. J Neurosurg 1986; 65(5)636–41
  • Woischneck D, Gaab M R. Intracranial pressure with head elevation. J Neurosurg 1992; 77(4)651–2
  • Silver F L, Norris J W, Lewis A J, Hachinski V C. Early mortality following stroke: a prospective review. Stroke 1984; 15(3)492–6
  • Frank J I. Large hemispheric infarction, deterioration, andintracranial pressure. Neurology 1995; 45(7)1286–90
  • Schwarz S, Georgiadis D, Aschoff A, Schwab S. Effects of body position on intracranial pressure andcerebral perfusion in patients with large hemispheric stroke. Stroke 2002; 33(2)497–501
  • Wojner-Alexander A W, Garami Z, Chernyshev O Y, Alexandrov A V. Heads down: flat positioning improves blood flow velocity in acute ischemic stroke. Neurology 2005; 64(8)1354–7
  • Rowat A M, Dennis M S, Wardlaw J M. Hypoxaemia in acute stroke is frequent andworsens outcome. Cerebrovasc Dis 2006; 21(3)166–72
  • Singhal A B, Wang X, Sumii T, Mori T, Lo E H. Effects of normobaric hyperoxia in a rat model of focal cerebral ischemia-reperfusion. J Cereb Blood Flow Metab 2002; 22(7)861–8
  • Singhal A B, Dijkhuizen R M, Rosen B R, Lo E H. Normobaric hyperoxia reduces MRI diffusion abnormalities andinfarct size in experimental stroke. Neurology 2002; 58(6)945–52
  • Ronning O M, Guldvog B. Should stroke victims routinely receive supplemental oxygen? A quasi-randomized controlled trial. Stroke 1999; 30(10)2033–7
  • Singhal A B, Benner T, Roccatagliata L, Koroshetz W J, Schaefer P W, Lo E H, Buonanno F S, Gonzalez R G, Sorensen A G. A pilot study of normobaric oxygen therapy in acute ischemic stroke. Stroke 2005; 36(4)797–802
  • Bennett M H, Wasiak J, Schnabel A, Kranke P, French C. Hyperbaric oxygen therapy for acute ischaemic stroke. Cochrane Database Syst Rev 2005, 3, CD004954
  • Omae T, Ibayashi S, Kusuda K, Nakamura H, Yagi H, Fujishima M. Effects of high atmospheric pressure andoxygen on middle cerebral blood flow velocity in humans measured by transcranial Doppler. Stroke 1998; 29(1)94–7
  • Watson N A, Beards S C, Altaf N, Kassner A, Jackson A. The effect of hyperoxia on cerebral blood flow: a study in healthy volunteers using magnetic resonance phase-contrast angiography. Eur J Anaesthesiol 2000; 17(3)152–9
  • Langhorne P, Tong B L, Stott D J. Association between physiological homeostasis andearly recovery after stroke. Stroke 2000; 31(10)2518–9
  • Evans A, Perez I, Harraf F, Melbourn A, Steadman J, Donaldson N, Kalra L. Can differences in management processes explain different outcomes between stroke unit andstroke-team care?. Lancet 2001; 358(9293)1586–92
  • Indredavik B, Bakke F, Slordahl S A, Rokseth R, Haheim L L. Treatment in a combined acute andrehabilitation stroke unit: which aspects are most important?. Stroke 1999; 30(5)917–23
  • Part 9: Adult Stroke. Circulation 2005; 112: IV111–IV120, (24_suppl)
  • Pace S A, Fuller F P, Dahlgren T J. Paramedic decisions with placement of out-of-hospital intravenous lines. Am J Emerg Med 1999; 17(6)544–7
  • Henderson R A, Thomson D P, Bahrs B A, Norman M P. Unnecessary intravenous access in the emergency setting. Prehosp Emerg Care 1998; 2(4)312–6
  • Slovis C M, Herr E W, Londorf D, Little T D, Alexander B R, Guthmann R J. Success rates for initiation of intravenous therapy en route by prehospital care providers. Am J Emerg Med 1990; 8(4)305–7
  • Kidwell C S, Chalela J A, Saver J L, Starkman S, Hill M D, Demchuk A M, Butman J A, Patronas N, Alger J R, Latour L L, Luby M L, Baird A E, Leary M C, Tremwel M, Ovbiagele B, Fredieu A, Suzuki S, Villablanca J P, Davis S, Dunn B, Todd J W, Ezzeddine M A, Haymore J, Lynch J K, Davis L, Warach S. Comparison of MRI andCT for detection of acute intracerebral hemorrhage. JAMA 2004; 292(15)1823–30
  • Fiebach J B, Schellinger P D, Gass A, Kucinski T, Siebler M, Villringer A, Olkers P, Hirsch J G, Heiland S, Wilde P, Jansen O, Rother J, Hacke W, Sartor K. Stroke magnetic resonance imaging is accurate in hyperacute intracerebral hemorrhage: a multicenter study on the validity of stroke imaging. Stroke 2004; 35(2)502–6
  • Asplund K. Haemodilution for acute ischaemic stroke. Cochrane Database Syst Rev 2002, 4, CD000103
  • Schwarz S, Georgiadis D, Aschoff A, Schwab S. Effects of hypertonic (10%) saline in patients with raised intracranial pressure after stroke. Stroke 2002; 33(1)136–40
  • Bhardwaj A, Harukuni I, Murphy S J, Alkayed N J, Crain B J, Koehler R C, Hurn P D, Traystman R J. Hypertonic saline worsens infarct volume after transient focal ischemia in rats. Stroke 2000; 31(7)1694–701
  • Bruno A, Biller J, Adams H P, Jr., Clarke W R, Woolson R F, Williams L S, Hansen M D. Acute blood glucose level andoutcome from ischemic stroke. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Neurology 1999; 52(2)280–4
  • Weir C J, Murray G D, Dyker A G, Lees K R. Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long-term follow up study. BMJ 1997; 314(7090)1303–6
  • Kelly J, Hunt B J, Lewis R R, Swaminathan R, Moody A, Seed P T, Rudd A. Dehydration andvenous thromboembolism after acute stroke. QJM 2004; 97(5)293–6
  • Bhalla A, Sankaralingam S, Dundas R, Swaminathan R, Wolfe C D, Rudd A G. Influence of raised plasma osmolality on clinical outcome after acute stroke. Stroke 2000; 31(9)2043–8
  • Laowattana S, Zeger S L, Lima J A, Goodman S N, Wittstein I S, Oppenheimer S M. Left insular stroke is associated with adverse cardiac outcome. Neurology 2006; 66(4)477–83, discussion 463
  • Oppenheimer S M, Hachinski V C. The cardiac consequences of stroke. Neurol Clin 1992; 10(1)167–76
  • Myers M G, Norris J W, Hachinski V C, Weingert M E, Sole M J. Cardiac sequelae of acute stroke. Stroke 1982; 13(6)838–42
  • Korpelainen J T, Sotaniemi K A, Makikallio A, Huikuri H V, Myllyla V V. Dynamic behavior of heart rate in ischemic stroke. Stroke 1999; 30(5)1008–13
  • Touze E, Varenne O, Chatellier G, Peyrard S, Rothwell P M, Mas J L. Risk of myocardial infarction andvascular death after transient ischemic attack andischemic stroke: a systematic review andmeta-analysis. Stroke 2005; 36(12)2748–55
  • Oppenheimer S M, Cechetto D F, Hachinski V C. Cerebrogenic cardiac arrhythmias. Cerebral electrocardiographic influences andtheir role in sudden death. Arch Neurol 1990; 47(5)513–9
  • Lane R D, Wallace J D, Petrosky P P, Schwartz G E, Gradman A H. Supraventricular tachycardia in patients with right hemisphere strokes. Stroke 1992; 23(3)362–6
  • Huff J S. Stroke mimics andchameleons. Emerg Med Clin North Am 2002; 20(3)583–95
  • Bruno A, Levine S R, Frankel M R, Brott T G, Lin Y, Tilley B C, Lyden P D, Broderick J P, Kwiatkowski T G, Fineberg S E. Admission glucose level andclinical outcomes in the NINDS rt-PA Stroke Trial. Neurology 2002; 59(5)669–74
  • Berger L, Hakim A M. The association of hyperglycemia with cerebral edema in stroke. Stroke 1986; 17(5)865–71
  • Demchuk A M, Morgenstern L B, Krieger D W, Linda Chi T, Hu W, Wein T H, Hardy R J, Grotta J C, Buchan A M. Serum glucose level anddiabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke. Stroke 1999; 30(1)34–9
  • Gentile N T, Seftchick M W, Huynh T, Kruus L K, Gaughan J. Decreased mortality by normalizing blood glucose after acute ischemic stroke. Acad Emerg Med 2006; 13(2)174–80
  • Walters M R, Weir C J, Lees K R. A Randomised, Controlled pilot study to investigate the potential benefit of intervention with insulin in hyperglycaemic acute ischaemic stroke patients. Cerebrovasc Dis 2006; 22(2-3)116–22
  • Johnston K. Glucose Regulation in Acute Stroke Patient Trial. Stroke Trials Registry, http://www.strokecenter.org/trials Updated on 03/02/06. Available at, Accessed May 18, 2006
  • Bruno A. Treatment of hyperglycemia in ischemic stroke. Stroke Trials Registry, http://www.strokecenter.org/trials Updated on 02/16/06. Available at, Accessed May 18, 2006
  • Sandercock P, Gubitz G, Foley P, Counsell C. Antiplatelet therapy for acute ischaemic stroke. Cochrane Database Syst Rev 2003, 2, CD000029
  • Easton J D. What have we learned from recent antiplatelet trials?. Neurology 1998; 51: S36–38, (3 suppl 3)
  • The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group. Lancet 1997; 349(9065)1569–81
  • CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group. Lancet 1997; 349(9066)1641–9
  • Chen Z M, Sandercock P, Pan H C, Counsell C, Collins R, Liu L S, Xie J X, Warlow C, Peto R. Indications for early aspirin use in acute ischemic stroke: a combined analysis of 40 000 randomized patients from the chinese acute stroke trial andthe international stroke trial. On behalf of the CAST andIST collaborative groups. Stroke 2000; 31(6)1240–9
  • Schmulling S, Rudolf J, Strotmann-Tack T, Grond M, Schneweis S, Sobesky J, Thiel A, Heiss W D. Acetylsalicylic acid pretreatment, concomitant heparin therapy andthe risk of early intracranial hemorrhage following systemic thrombolysis for acute ischemic stroke. Cerebrovasc Dis 2003; 16(3)183–90
  • He J, Whelton P K, Vu B, Klag M J. Aspirin andrisk of hemorrhagic stroke: a meta-analysis of randomized controlled trials. JAMA 1998; 280(22)1930–5
  • Gorelick P B, Weisman S M. Risk of hemorrhagic stroke with aspirin use: an update. Stroke 2005; 36(8)1801–7
  • Spengos K, Tsivgoulis G, Zakopoulos N. Blood pressure management in acute stroke: a long-standing debate. Eur Neurol 2006; 55(3)123–35
  • Willmot M, Leonardi-Bee J, Bath P M. High blood pressure in acute stroke andsubsequent outcome: a systematic review. Hypertension 2004; 43(1)18–24
  • Bath P. High blood pressure as risk factor andprognostic predictor in acute ischaemic stroke: when andhow to treat it?. Cerebrovasc Dis 2004; 17: 51–7, (suppl 1)
  • Broderick J, Brott T, Barsan W, Haley E C, Levy D, Marler J, Sheppard G, Blum C. Blood pressure during the first minutes of focal cerebral ischemia. Ann Emerg Med 1993; 22(9)1438–43
  • Oliveira-Filho J, Silva S C, Trabuco C C, Pedreira B B, Sousa E U, Bacellar A. Detrimental effect of blood pressure reduction in the first 24 hours of acute stroke onset. Neurology 2003; 61(8)1047–51
  • Castillo J, Leira R, Garcia M M, Serena J, Blanco M, Davalos A. Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury andpoor stroke outcome. Stroke 2004; 35(2)520–6
  • Vlcek M, Schillinger M, Lang W, Lalouschek W, Bur A, Hirschl M M. Association between course of blood pressure within the first 24 hours andfunctional recovery after acute ischemic stroke. Ann Emerg Med 2003; 42(5)619–26
  • Hillis A E, Ulatowski J A, Barker P B, Torbey M, Ziai W, Beauchamp N J, Oh S, Wityk R J. A pilot randomized trial of induced blood pressure elevation: effects on function andfocal perfusion in acute andsubacute stroke. Cerebrovasc Dis 2003; 16(3)236–46
  • Chalela J A, Dunn B, Todd J W, Warach S. Induced hypertension improves cerebral blood flow in acute ischemic stroke. Neurology 2005; 64(11)1979
  • Adams H, Adams R, Del Zoppo G, Goldstein L B. Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update a scientific statement from the Stroke Council of the American Heart Association/American Stroke Association. Stroke 2005; 36(4)916–23
  • Broderick J P, Adams H P, Jr, Barsan W, Feinberg W, Feldmann E, Grotta J, Kase C, Krieger D, Mayberg M, Tilley B, Zabramski J M, Zuccarello M. Guidelines for the management of spontaneous intracerebral hemorrhage: A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1999; 30(4)905–15
  • Alberts M J, Hademenos G, Latchaw R E, Jagoda A, Marler J R, Mayberg M R, Starke R D, Todd H W, Viste K M, Girgus M, Shephard T, Emr M, Shwayder P, Walker M D. Recommendations for the establishment of primary stroke centers. Brain Attack Coalition. JAMA 2000; 283(23)3102–9
  • Joint Commission's Certificate of Distinction for Primary Stroke Centers. Joint Commission on Accreditation of Healthcare Organizations, http://www.jcaho.org/dscc/dsc/certification+information/stroke_brochure.pdf Available at, Accessed October 24, 2005
  • Langhorne P, Williams B O, Gilchrist W, Howie K. Do stroke units save lives?. Lancet 1993; 342(8868)395–8
  • Indredavik B, Bakke F, Solberg R, Rokseth R, Haaheim L L, Holme I. Benefit of a stroke unit: a randomized controlled trial. Stroke 1991; 22(8)1026–31
  • Wood-Dauphinee S, Shapiro S, Bass E, Fletcher C, Georges P, Hensby V, Mendelsohn B. A randomized trial of team care following stroke. Stroke 1984; 15(5)864–72
  • Sivenius J, Pyorala K, Heinonen O P, Salonen J T, Riekkinen P. The significance of intensity of rehabilitation of stroke–a controlled trial. Stroke 1985; 16(6)928–31
  • Strand T, Asplund K, Eriksson S, Hagg E, Lithner F, Wester P O. A non-intensive stroke unit reduces functional disability andthe need for long-term hospitalization. Stroke 1985; 16(1)29–34
  • Wojner-Alexandrov A W, Alexandrov A V, Rodriguez D, Persse D, Grotta J C. Houston paramedic andemergency stroke treatment andoutcomes study (HoPSTO). Stroke 2005; 36(7)1512–8
  • Goldstein L B, Matchar D B, Hoff-Lindquist J, Samsa G P, Horner R D. VA Stroke Study: neurologist care is associated with increased testing but improved outcomes. Neurology 2003; 61(6)792–6
  • Mitchell J B, Ballard D J, Whisnant J P, Ammering C J, Samsa G P, Matchar D B. What role do neurologists play in determining the costs andoutcomes of stroke patients?. Stroke 1996; 27(11)1937–43
  • Primary Stroke Center Certification. Joint Commission on Acredidation of Healthcare Organizations, http://www.jcaho.org/dscc/psc/index.htm Available at, Accessed October 24, 2005
  • Disease-Specific Care Certification Program. Joint Commission on Accredidation of Healthcare Organizations, http://www.jcaho.org/dscc/psc/guide.htm Available at, Accessed October 24, 2005

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.